Last edition
News about "Terns Pharmaceuticals"
Merck Completes USD 5.8 Billion Acquisition of Terns Pharmaceuticals to Strengthen Oncology Pipeline
Merck acquires Terns Pharmaceuticals, advancing development of next-generation therapies for chronic myeloid leukaemia.
Terns Pharmaceuticals | 06/05/2026 | By News Bureau
Merck & Co. is reportedly nearing a USD 6 billion acquisition of Terns Pharmaceuticals, as part of its strategy to strengthen its oncology portfolio and prepare for future growth.
Terns Pharmaceuticals | 25/03/2026 | By Darshana | 155
Terns Prices Upsized USD 650 Million Public Offering
Terns plans to use the proceeds to advance research and clinical development of its pipeline, including TERN-701, support early commercial launch preparations, and fund working capital and general corporate needs.
Terns Pharmaceuticals | 10/12/2025 | By Akanki | 180
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy